Latest Form 4 insider transactions

Traci S Umberger, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 3,580 shares of common stock on August 4, 2026 for $24.04 per share.

Michael Lieb, Chief Accounting Officer of Unity Software Inc., received 38,948 shares of common stock on August 4, 2026.

David Overton, CHAIRMAN AND C.E.O. and a Director of Cheesecake Factory Inc, sold 94,145 shares of common stock on August 5, 2026 for $106.27 per share.

Brian Daniel Webster, See Remarks and a Director of Kestra Medical Technologies, Ltd., sold 51,900 shares of common stock on August 4, 2026.

Alexander L Cappello, a Director of Cheesecake Factory Inc, sold 64 shares of common stock on August 4, 2026 for $106.08 per share.

Christian H. Charnaux, See remarks of Hilton Worldwide Holdings Inc., reported a transaction in 1,854 shares of common stock on August 5, 2026.

Ron Vincent, Chief Financial Officer of Crexendo, Inc., reported multiple transactions in common stock on August 4, 2026.

Echavarria Luis Fernando Restrepo, a Director of Grupo Cibest S.A., reported a transaction in 26,016 shares of common stock on August 6, 2026.

C. David Allen Jr, a Director of Bgsf, Inc., reported multiple transactions in common stock on August 4, 2026.

Ron Vincent, Chief Financial Officer of Crexendo, Inc., reported multiple transactions in common stock on August 4, 2026.

Debra Zack, Chief Medical Officer of Spero Therapeutics, Inc., reported multiple transactions in common stock on August 3, 2026.

Richard L Baum Jr, a Director of Bgsf, Inc., reported multiple transactions in common stock on August 4, 2026.

Jeffrey G Korn, Chief Executive Officer of Crexendo, Inc., reported multiple transactions in common stock on August 4, 2026.

Bryan Timm, a Director of Qt Imaging Holdings, Inc., received 9,000 shares of common stock on August 4, 2026.

Donna Carroll, a Director of Bgsf, Inc., reported multiple transactions in common stock on August 4, 2026.

William Guyer, Chief Development Officer of Corcept Therapeutics Inc, sold 3,700 shares of common stock on August 4, 2026 for $113.12 per share.

Douglas Walter Gaylor, Chief Operating Officer of Crexendo, Inc., reported multiple transactions in common stock on August 4, 2026.

Julia Blunden, a Director of Nextracker Inc., sold 2,289 shares of common stock on August 5, 2026 for $97.22 per share.

Brooks J Klimley, a Director of Antero Midstream Corp, sold 5,000 shares of common stock on August 6, 2026 for $21.27 per share.

Douglas Hailey, a Director of Bgsf, Inc., reported multiple transactions in common stock on August 4, 2026.

Leonardo Pareja, CEO of eXp Realty of EXP World Holdings, Inc., reported multiple transactions in common stock on August 6, 2026.

Jesse P. Hill, Chief Financial Officer of EXP World Holdings, Inc., reported multiple transactions in common stock on August 5, 2026.

Paul Seid, a Director of Bgsf, Inc., reported multiple transactions in common stock on August 4, 2026.

Mark W Peterson, Chief Administrative Officer of Zurn Elkay Water Solutions Corp, sold 25,000 shares of common stock on August 4, 2026 for $53.02 per share.

Kathleen E Johnson, Chief Executive Officer and a Director of Lumen Technologies, Inc., purchased 100,000 shares of common stock on August 6, 2026 for $6.13 per share.

Andrew Rees, Chief Executive Officer and a Director of Crocs, Inc., reported multiple transactions in common stock on August 4, 2026.

Alexander Otto, a Director of Curbline Properties Corp., sold 173,057 shares of common stock on August 4, 2026.

John M Hinshaw, a Director of Lumen Technologies, Inc., received 27,350 shares of common stock on August 5, 2026.

Charles Protell, a Director of Dave & Buster's Entertainment, Inc., received 784 shares of common stock on August 5, 2026.

Kinney Horn, CHIEF BUSINESS OFFICER of Immunome Inc., sold 90,616 shares of common stock on August 4, 2026 for $25.09 per share.